Deltec Asset Management’s GeneDx Holdings WGS Stock Holding History

Deltec Asset Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-455	Closed	-$46K	–	258
2022 Q1	$46K	Hold	455	–	–	0.01%	252
2021 Q4	$67K	Hold	455	–	–	0.01%	245
2021 Q3	$114K	Sell	455 -303	-40%	-$104K	0.02%	267
2021 Q2	$350K	Sell	758 -292	-28%	-$125K	0.05%	232
2021 Q1	$516K	Sell	1,050 -707	-40%	-$368K	0.08%	172
2020 Q4	$640K	Buy	+1,757	New	+$612K	0.1%	143

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Deltec Asset Management's WGS Position: Q2 2022 in Review

Deltec Asset Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 455 shares — an estimated $46K sold.

Deltec Asset Management first reported a position in WGS in Q4 2020 and held it in 6 quarters. The position peaked at $640K in Q4 2020. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

Deltec Asset Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
Deltec Asset Management sold 455 GeneDx Holdings shares in Q2 2022, an estimated $46K.
Deltec Asset Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 6 quarters.
Deltec Asset Management's GeneDx Holdings position peaked at $640K in Q4 2020.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Deltec Asset Management's 13F filing for Q2 2022, filed 18 Jul 2022.